Hodgkin's disease in HIV-infected patients: report of eight cases usefully treated with doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD) plus granulocyte colony- stimulating factor

Ann Oncol. 2002 Jul;13(7):1158-60. doi: 10.1093/annonc/mdf239.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Antiretroviral Therapy, Highly Active
  • Bleomycin / administration & dosage*
  • Dacarbazine / administration & dosage*
  • Dose-Response Relationship, Drug
  • Doxorubicin / administration & dosage*
  • Drug Administration Schedule
  • Female
  • Granulocyte Colony-Stimulating Factor / administration & dosage*
  • HIV Infections / complications*
  • HIV Infections / diagnosis
  • HIV Infections / drug therapy*
  • Hodgkin Disease / complications*
  • Hodgkin Disease / diagnosis
  • Hodgkin Disease / drug therapy*
  • Humans
  • Infusions, Intravenous
  • Male
  • Prognosis
  • Risk Assessment
  • Sampling Studies
  • Survival Rate
  • Treatment Outcome
  • Vinblastine / administration & dosage*

Substances

  • Bleomycin
  • Granulocyte Colony-Stimulating Factor
  • Vinblastine
  • Dacarbazine
  • Doxorubicin

Supplementary concepts

  • ABVD protocol